Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study H Gisslinger, C Klade, P Georgiev, D Krochmalczyk, ... The Lancet Haematology 7 (3), e196-e208, 2020 | 252 | 2020 |
Acute lymphoblastic leukemia in the elderly: the Edouard Herriot Hospital experience X Thomas, N Olteanu, C Charrin, V Lhéritier, JP Magaud, D Fiere American journal of hematology 67 (2), 73-83, 2001 | 95 | 2001 |
Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome. X Thomas, A Thiebaut, N Olteanu, C Danaila, C Charrin, E Archimbaud, ... Hematology and cell therapy 40 (3), 119-128, 1998 | 92 | 1998 |
Abnormalities of platelet aggregation in chronic myeloproliferative disorders S Avram, A Lupu, S Angelescu, NDMP Olteanu Journal of Cellular and Molecular Medicine 5 (1), 79-87, 2001 | 61 | 2001 |
MECOM, HBS1L‐MYB, THRB‐RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients AP Trifa, C Bănescu, AS Bojan, CM Voina, Ș Popa, S Vișan, AD Ciubean, ... American Journal of Hematology 93 (1), 100-106, 2018 | 41 | 2018 |
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms … AP Trifa, C Bănescu, M Tevet, A Bojan, D Dima, L Urian, T Török‐Vistai, ... British Journal of Haematology 174 (2), 218-226, 2016 | 39 | 2016 |
Value of multifaced approach diagnosis and classification of acute leukemias S Angelescu, NM Berbec, A Colita, D Barbu, AR Lupu Mædica 7 (3), 254, 2012 | 24 | 2012 |
Increased Dkk‐1 plasma levels may discriminate disease subtypes in myeloproliferative neoplasms C Mambet, L Necula, S Mihai, L Matei, C Bleotu, M Chivu‐Economescu, ... Journal of Cellular and Molecular Medicine 22 (8), 4005-4011, 2018 | 9 | 2018 |
Von Willebrand disease type 2 in pregnancy− a critical clinical association AA Simionescu, NF Buinoiu, N Berbec Transfusion and Apheresis Science 56 (3), 269-271, 2017 | 9 | 2017 |
Delineation of molecular lesions in acute myeloid leukemia patients at diagnosis: integrated next generation sequencing and cytogenomic studies SM Papuc, A Erbescu, D Cisleanu, D Ozunu, C Enache, I Dumitru, ... Genes 12 (6), 846, 2021 | 5 | 2021 |
Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms C Mambet, O Babosova, JP Defour, E Leroy, L Necula, O Stanca, A Tatic, ... Blood, The Journal of the American Society of Hematology 132 (25), 2695-2699, 2018 | 5 | 2018 |
Particular clinical and therapeutical aspects in acute myeloid leukemia in elderly patients A Colita, A Colita, NM Berbec, S Angelescu, AR Lupu Maedica 6 (4), 287, 2011 | 5 | 2011 |
Eosinophil activation markers in clonal and non-clonal eosinophilia S Angelescu, C Mambet, DIM Popescu, NM Berbec, A Costache, ... Revista Romana de Medicina de Laborator 21 (3), 311-320, 2013 | 3 | 2013 |
Molecular characterization of complex chromosomal changes in de novo acute myeloid leukemia: a case report NP Berbec, SMF Papuc, ACDF Tutulan-Cunita, SM Angelescu, AI Lupu, ... Revista Romana de Medicina de Laborator 21 (1), 59-65, 2013 | 3 | 2013 |
Importance of assessing cytogenetic and molecular risk factors in acute myeloid leukemia therapy EC Coles, A Colita, R Momanu, N Berbec, AM Ivanescu, M Oprea, ... Journal of Medicine and Life 5 (Spec Issue), 36, 2012 | 3 | 2012 |
Relationship between chromosomal changes complexity and disease aggressiveness in myeloid and lymphoid disorders A Lungeanu, A Arghir, A Lupu, DM Popescu, N Berbec Journal of Cellular and Molecular Medicine 6 (3), 389-398, 2002 | 3 | 2002 |
APPLY: A prospective observational study of clinical practice patterns of darbepoetin alfa use in patients with chemotherapy-induced anemia in Romania NM Berbec, DL Stanculeanu, NS Badelita, M Vasilica, DI Popovici, ... memo-Magazine of European Medical Oncology 11, 144-151, 2018 | 2 | 2018 |
A Review of FLT3 Kinase Inhibitors in AML C Negotei, A Colita, I Mitu, AR Lupu, ME Lapadat, CE Popovici, ... Journal of Clinical Medicine 12 (20), 6429, 2023 | 1 | 2023 |
Assessment of Impact of Human Leukocyte Antigen-Type and Cytokine-Type Responses on Outcomes after Targeted Therapy Currently Used to Treat Chronic Lymphocytic Leukemia M Andreescu, N Berbec, AD Tanase Journal of Clinical Medicine 12 (7), 2731, 2023 | 1 | 2023 |
Misinterpretation of Hematological Changes in Pregnancy and Postpartum Hemorrhage Due to Leukemia and Pregnancy AA Simionescu, N Berbec J Reprod Med 62, 000-000, 2017 | 1 | 2017 |